Baupost Took $461 Million Allergan Stake Before Deal Fell Apart


Seth Klarman's Baupost Group took a new position last quarter in Allergan Plc, before the drugmaker's $160 billion merger with Pfizer Inc. was terminated last month. Klarman bought 1.72 million shares of Allergan, which had a value of $461 million at the end of the first quarter, according to a regulatory filing today.



from Biotech News